Rivaroxaban 20mg Tablet in PCD pharma franchise in Hyderabad

Rivaroxaban 20mg Tablet in pharmaceutical manufacturing company in Mumbai

Rivaroxaban 20mg Tablet in anticoagulant pharma franchise in Pune

Rivaroxaban 20mg Tablet in pharma suppliers in Delhi

Rivaroxaban 20mg Tablet in pharma export companies in Kolkata
Rivaroxaban 20mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /rivaroxaban-20-mg-tablet

Rivafoli 20 tablet

Composition : Rivaroxaban 20 mg tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x14

Price : ₹1/-

Rivaroxaban 20 Tablet is a potent oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by selectively blocking the activity of Factor Xa, which plays a vital role in the formation of thrombin and subsequent clot development. This formulation is widely used in long-term anticoagulant therapy to prevent and treat venous thromboembolism, as well as in stroke prevention in patients with non-valvular atrial fibrillation. Its predictable pharmacokinetics allow fixed once-daily dosing without the need for routine coagulation monitoring, improving patient compliance and convenience.

Read More

About the Product

Rivaroxaban 20 Tablet is a potent oral anticoagulant belonging to the class of direct Factor Xa inhibitors. It works by selectively blocking the activity of Factor Xa, which plays a vital role in the formation of thrombin and subsequent clot development. This formulation is widely used in long-term anticoagulant therapy to prevent and treat venous thromboembolism, as well as in stroke prevention in patients with non-valvular atrial fibrillation. Its predictable pharmacokinetics allow fixed once-daily dosing without the need for routine coagulation monitoring, improving patient compliance and convenience.

Common side effects may include hyperkalemia, dizziness, or fatigue; rare side effects should be discussed with a healthcare provider.

Rivaroxaban 20 mg is indicated for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation with one or more risk factors. It is also prescribed for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Additionally, it is used to reduce the risk of recurrence in patients with previous thromboembolic events.

Consult a doctor before use, especially if you have kidney issues, high potassium levels, or are taking other medications. Regular monitoring of potassium levels is advised.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation